+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Neuropathic Pain"

Non-Opioid Pain Patch Market Report 2025 - Product Thumbnail Image

Non-Opioid Pain Patch Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Pain Management Drugs Market Report 2025 - Product Thumbnail Image

Pain Management Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Prescription Pain Medication Global Market Report 2025 - Product Thumbnail Image

Prescription Pain Medication Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
Post Operative Pain Management Global Market Report 2025 - Product Thumbnail Image

Post Operative Pain Management Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
From
Pain Management Devices Market - Global Forecast 2025-2030 - Product Thumbnail Image

Pain Management Devices Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 186 Pages
  • Global
From
Pain Management Devices and Therapies Market Report 2025 - Product Thumbnail Image

Pain Management Devices and Therapies Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Acute Pain- Pipeline Insight, 2025 - Product Thumbnail Image

Acute Pain- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Cyclo-oxygenase 2 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Cyclo-oxygenase 2 Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 90 Pages
  • Global
From
From
TRPV1 Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

TRPV1 Receptor Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Diabetic Neuropathic Pain- Pipeline Insight, 2025 - Product Thumbnail Image

Diabetic Neuropathic Pain- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Ocular Pain - Pipeline Insight, 2025 - Product Thumbnail Image

Ocular Pain - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 65 Pages
  • Global
From
Advanced Cancer Pain Management - Pipeline Insight, 2025 - Product Thumbnail Image

Advanced Cancer Pain Management - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Complex Regional Pain Syndromes- Pipeline Insight, 2025 - Product Thumbnail Image

Complex Regional Pain Syndromes- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Pregabalin - Global Strategic Business Report - Product Thumbnail Image

Pregabalin - Global Strategic Business Report

  • Report
  • September 2025
  • 372 Pages
  • Global
From
Oxycodone Hydrochloride - Global Strategic Business Report - Product Thumbnail Image

Oxycodone Hydrochloride - Global Strategic Business Report

  • Report
  • September 2025
  • 361 Pages
  • Global
From
Cancer Pain Management - Global Strategic Business Report - Product Thumbnail Image

Cancer Pain Management - Global Strategic Business Report

  • Report
  • September 2025
  • 588 Pages
  • Global
From
Loading Indicator

Neuropathic pain is a type of chronic pain caused by damage to the nervous system. It is often described as a burning, tingling, or shooting sensation. Analgesics are medications used to reduce or eliminate pain. Neuropathic pain is often treated with a combination of analgesics, including non-steroidal anti-inflammatory drugs (NSAIDs), opioids, and anticonvulsants. Other treatments may include physical therapy, nerve blocks, and electrical stimulation. The neuropathic pain market is a rapidly growing segment of the analgesics market. It is driven by the increasing prevalence of chronic pain conditions, such as diabetes, cancer, and multiple sclerosis. The market is expected to benefit from the development of novel treatments, such as gene therapy and stem cell therapy. Some companies in the neuropathic pain market include Pfizer, Johnson & Johnson, GlaxoSmithKline, Novartis, and Eli Lilly. Show Less Read more